Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Long-Term Debt Issuances (2018 - 2020)

Updated

Reviva Pharmaceuticals Holdings' Long-Term Debt Issuances was $3.11 million in FY2020, compared with $100,000 in FY2019.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Long-Term Debt Issuances (2018 - 2020) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $100,000 in FY2019 and $363,436 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.98 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2020 375,000.00
May 31, 2018 56,045.00
API Access

Reviva Pharmaceuticals Holdings Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RVPH&period=max&api_key=YOUR_API_KEY